Ratio of the R and S enantiomers of salsolinol in food and human urine

M. Strolin Benedetti, V. Bellotti, E. Pianezzola, +3

Journal of Neural Transmission

Human UrineBiochemistryMedicineDrug DiscoveryS Enantiomers +3

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

E. Moro, V. Bellotti, M.G. Jannuzzo, +2

Journal of Chromatography B Biomedical Sciences and Applications

Pharmacokinetic StudiesMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine +9

Bioavailability and Pharmacokinetics in Man of Acipimox, a New Antilipolytic and Hypolipemic Agent

L. Musatti, E. Maggi, E. Moro, +2

Journal of International Medical Research

Autoinduction of rifabutin metabolism in man

M. Strolin Benedetti, C. Efthymiopoulos, D Sassella, +2

Xenobiotica

Correlation Between Catechin Content and NF-κB Inhibition by Infusions of Green and Black Tea

Chiara Di Lorenzo, Mario Dell’Agli, Enrico Sangiovanni, +5

Plant Foods for Human Nutrition

Molecular PharmacologyFood Bioactive CompoundMedicineImmunologyBlack Tea +6

Development and Testing of a Silver Chloride-Impregnated Activated Carbon for Aqueous Removal and Sequestration of Iodide

Tanju Karanfil, E. Moro, Steven M. Serkiz

Environmental Technology

Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin?

Chiara Di Lorenzo, E. Moro, Ariana Dos Santos, +2

Drug Testing and Analysis

Pharmacokinetics of the enantiomers of indoprofen in man.

V. Tamassia, M.G. Jannuzzo, E. Moro, +3

PubMed

Medicinal ChemistryPharmacokinetic ModelingAsymmetric Carbon AtomPharmacological StudyMedicine +7

Determination of the enantiomeric composition of salsolinol in biological samples by high-performance liquid chromatography with electrochemical detection

E. Pianezzola, V. Bellotti, E. Fontana, +3

Journal of Chromatography B Biomedical Sciences and Applications

BiochemistryActive IngredientElectrochemical DetectionMedicineBioanalysis +9

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

L. M. Fuccella, G Corvi, E. Moro, +3

European Journal of Clinical Pharmacology

ThrombopoiesisThrombosisBlood PlateletMedicinePlatelet Aggregation +7